{
Arcus Biosciences, Inc.

Companies

}
001122334455554433221100
001122334455554433221100

setbacks in drug development impact schizophrenia and oncology markets

AbbVie's schizophrenia drug emraclidine failed two mid-phase trials, performing no better than placebo, resulting in a $40 billion market cap loss for the company. This setback follows the recent approval of Bristol Myers Squibb's Cobenfy, the first new schizophrenia drug in decades, which boosted BMS's share price by 12%. The failure raises concerns for other companies developing similar drugs in the same class.
PharmaVoice
Arcus Biosciences, Inc. Hoffmann-La Roche AG Gilead Sciences, Inc. Biohaven Ltd. Merck & Co., Inc. Genentech Cassava Sciences, Inc. ABBVIE Bristol-Myers Squibb Co BioAge Labs, Inc. USA Jean Rochefort Show more
Finance & Economy, Market Report
01:00 16.12.2024
Trending
Subcategory
Stock Market Updates Corporate News Industry Trends Global Trade Developments Global Financial Events Finance Mergers & Acquisitions Banking Regulations Retail and Consumer Goods Startups & Entrepreneurship Central Bank Actions Industry Mergers & Acquisitions Inflation and Monetary Impact Government Economic Policies Market Analysis and Predictions CEO Changes Domestic Politics Government Policies Workplace Trends GDP Growth & Recession Forecasts Financial Scams and Security
Countries:
USA CHN CHE GBR IND DEU FRA JPN CAN VNM ESP ITA ARE MEX SGP AUS TWN THA MYS EGY
Companies:
JPMorgan Chase & Co. Tesla, Inc. Apple Inc. Barclays PLC Deutsche Bank Money Market PP The Goldman Sachs Group, Inc. Credit Suisse Strategic Income I Banco Santander, S.A. Berkshire Hathaway Inc. UBS Group AG Lloyds Banking Group plc SpaceXCoin USD Morgan Stanley Amazon.com, Inc. Bank of America Corporation Wells Fargo & Company BNP Paribas SA NVIDIA Corporation Bank Frick AG UniCredit S.p.A.
Currencies:
United States Dollar Euro British Pound Sterling Swiss Franc Japanese Yen Indian Rupee Chinese Yuan Vietnamese Đồng South Korean Won Canadian Dollar Australian Dollar Thai Baht New Taiwan Dollar Singapore Dollar Indonesian Rupiah Mexican Peso Cambodian Riel Russian Ruble Hong Kong Dollar Offshore Chinese Yuan
People:
Donald Trump Elon Musk Warren Buffett JD Vance Sergio Ermotti Mark Haefele Robin Leopold Troy L Rohrbaugh Jennifer Piepszak Olivier Calvet Karoline Leavitt Ursula von der Leyen Scott Bessent Stacey Friedman George Saravelos Alex Kramm Susan P. Crawford Francois Xavier Bouvignies Joseph Spak Stefan Rauti

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.